Amira Nature Foods Ltd
RYCE
RYCE was delisted on the 17th of August, 2020.
11 hedge funds and large institutions have $65.2K invested in Amira Nature Foods Ltd in 2020 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 1 closing their positions.
8% less funds holding
Funds holding: 12 → 11 (-1)
44% less capital invested
Capital invested by funds: $117K → $65.2K (-$52.1K)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Osaic Holdings
Scottsdale,
Arizona
|
+$1.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$63K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$9.33K |
| 3 |
Morgan Stanley
New York
|
-$1.52K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$764 |
RYCE Hedge Fund Activity: Q2 2020 in Review
11 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Amira Nature Foods Ltd (RYCE) for Q2 2020, worth a combined $65.2K — down 44% from $117K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of RYCE and 0 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 1 added.
The largest buyer was Osaic Holdings, adding an estimated $1.1K. The largest seller was Goldman Sachs, exiting entirely with an estimated $63K sold.
- 11 institutional investors held Amira Nature Foods Ltd (RYCE) as of Q2 2020, down from 12 in Q1 2020.
- Funds reported $65.2K of Amira Nature Foods Ltd stock for Q2 2020, down 44% quarter-over-quarter.
- 0 funds opened new Amira Nature Foods Ltd positions in Q2 2020 and 1 closed out, a net change of -1 holder.
- The largest Amira Nature Foods Ltd buyer in Q2 2020 was Osaic Holdings, an estimated $1.1K added.
- The largest Amira Nature Foods Ltd seller in Q2 2020 was Goldman Sachs, an estimated $63K sold.
Based on aggregated 13F filings for Q2 2020.